Microglia, the only lifelong resident immune cells of the central nervous system (CNS), are highly specialized macrophages that have been recognized to have a crucial role in neurodegenerative diseases such as Alzheimer's, Parkinson's and adrenoleukodystrophy (ALD). However, in contrast to other cell types of the human CNS, bona fide microglia have not yet been derived from cultured human pluripotent stem cells. Here we establish a robust and efficient protocol for the rapid production of microglia-like cells from human (h) embryonic stem (ES) and induced pluripotent stem (iPS) cells that uses defined serumfree culture conditions. These in vitro pluripotent stem cell-derived microglia-like cells (termed pMGLs) faithfully recapitulate the expected ontogeny and characteristics of their in vivo counterparts, and they resemble primary fetal human and mouse microglia. We generated these cells from multiple disease-specific cell lines and find that pMGLs derived from an hES model of Rett syndrome are smaller than their isogenic controls. We further describe a platform to study the integration and live behavior of pMGLs in organotypic 3D cultures. This modular differentiation system allows for the study of microglia in highly defined conditions as they mature in response to developmentally relevant cues, and it provides a framework in which to study the long-term interactions of microglia residing in a tissue-like environment.
Microglia are the resident macrophages of the central nervous system (CNS) 1 . Expanding on previous developmental studies 2,3 , recent genetic-lineage tracing in the mouse determined that microglia take up residence in the developing neural tube shortly before closure of the blood-brain barrier 4 . They emigrate as erythromyeloid precursors or primitive macrophages from the yolk sac before further hematopoiesis takes place in the periphery. In contrast to other adult tissue monocyte-derived macrophages, microglial identity is a combination of unique mesodermal ontogeny (primitive myelopoiesis) and lifelong residence in an immune-privileged neuroglial environment. Their phenotype is shaped by the developmental stages of the nervous system as it transitions from neurogenesis and gliogenesis to synaptogenesis and network maturation 5 , and then to a largely postmitotic aging tissue in the absence of injury.
Microglia have emerged in recent years as primary modulators of both the development and pathogenesis of the nervous system, urgently requiring study. However, unlike bone marrow-and monocytederived macrophages, primary human microglia remain poorly characterized because they differ greatly from mature mouse microglia and are not easily accessible, and current methods employed for isolation probably alter their defining characteristics 6 . In vitro approaches to modeling and studying CNS disorders using human iPS-and ES-derived cultures are currently lacking this important component. Robust protocols have been developed to induce human ES or iPS cells to differentiate into the different neuroectodermal cell types of the CNS, including neurons, astrocytes and oligodendrocytes 7, 8 . Protocols recapitulating classical hematopoiesis, followed by the expansion of monocytes, have shown that myeloid cells can be generated from mouse and human ES cells 9 . However, the generation of microglia-like cells that match the recently identified signatures of acutely isolated microglia 10, 11 , and following their nonmonocytic yolk sac ontogeny 4 , has not been reported from pluripotent human cells.
Here we describe an efficient method for generating microglia-like cells from human ES and iPS cells representing a collection of control and disease subjects. By using recent insights into microglial differentiation 12 , we show that microglia-like cells can be generated efficiently and enriched from multiple ES and iPS cell lines. Expression signatures of these iPS-derived microglia resemble those of purified human fetal microglia maintained in the same culture conditions and recapitulate the recently defined consensus signature of microglia, as compared to other macrophages 10, 11, 13 . They perform the functions of professional phagocytes, are positive for microglial markers such as TMEM119 and react to canonical stimuli. Our results provide a system to study the maturation and steady-state behavior of human microglia in a highly defined cellular environment and their involvement in disease onset, propagation and resolution.
Efficient derivation of microglia-like cells from human pluripotent stem cells RESULTS A basal medium for the maintenance of human and murine fetal microglia Serum-based media have been the mainstay of microglial isolation techniques over the years, but these undefined culture conditions might unpredictably alter their characteristics. Building on recent refinements of the work of Brewer and colleagues 14 , we have developed a fully defined, serum-free neuroglial differentiation (NGD) media, the component concentrations of which were adjusted to match those of human cerebrospinal fluid ( Supplementary Table 1 ). As compared to the complexity of other published culture conditions, NGD constitutes a single defined serum-free medium that enables the culturing of multiple neural and glial cell types, as well as other cells of interest. Neural differentiation can be initiated in NGD by the addition of a small molecule inhibitor of transforming growth factor (TGF)-β signaling (dorsomorphin) 15 . Neural progenitors can be expanded by the addition of fibroblast growth factor-2 (FGF2) to the NGD base, and differentiation into neurons and glia can be subsequently triggered by FGF2 removal.
To selectively culture microglia, we used commercially available modified polystyrene (Primaria) plates that allow for adherent maintenance of mouse neonatal microglia and human fetal microglia (mNMG and hFMG, respectively) while maintaining the possibility of enzymatic passaging ( Supplementary Fig. 1a ). By contrast, neuroglial derivatives from neural progenitors are poorly adherent and thus selected against on this substrate (data not shown). IL-34 and colony-stimulating factor 1 (CSF1), both important for microglia differentiation and maintenance in vivo 16, 17 , were added to the medium. Both human FMGs and mouse (m) NMGs died in the absence of any CSF1 receptor (CSF1R) agonist, with hFMGs adopting a more ramified morphology in the presence of high concentrations of IL-34 ( Supplementary Fig. 1a,b) . Primary cells could be maintained in this medium for more than a month without passaging, which suggests that this formulation might be generally useful for primary myeloid cultures.
Induction of primitive microglia from human pluripotent cells
Human ES or iPS cells were grown in hES medium on feeder layers of murine embryonic fibroblasts. After enzymatic passaging, uniform cell clusters-free of single cells-were used for initial embryoid-body seeding. These clusters were re-suspended directly in NGD (without stepwise adaptation) containing 10 ng/ml CSF1 and IL-34 (microglial differentiation medium, MGdM) in Corning ultra-low adherence plates. After 1 week, we observed the formation of two types of structure: dense, neuralized spheroids appearing alongside embryoid bodies forming cystic structures, bound by a single cell layer ( Fig. 1a) . When plated at these early stages on poly-d-lysine, the neuralized EBs flattened into typical rosette-forming neuroepithelium, whereas the small cystic EBs flattened into cell lawns reminiscent of endothelial cells 18 (Supplementary Fig. 1b ). Island whorls could be seen giving rise to 3D clusters of round cells at their borders, organizing themselves into ropes ( Fig. 1b) . Proliferation and growth of these structures after attachment is CSF1R-ligand dependent, given that they arrested and devolved in the absence of CSF1 and IL-34 (data not shown).
The cells at the island borders and in the 3D ropes were positive for VE-cadherin, c-kit CD41 and CD235a (Fig. 1b,c) , which have been identified in mice as markers of early yolk sac myelogenesis before definitive hematopoiesis or the establishment of embryonic circulation (<E8.5) 19 . This immuno-histochemical panel is consistent with these cells representing the in vitro counterparts of early haemogenic endothelia 20 . On the basis of this pattern of marker expression in the cystic EBs, we refer to them hereafter as yolk sac EBs (YS-EBs). Large domains of the YS-EBs were positive for the master myeloid transcription factor PU.1 (Fig. 1d) , which is necessary for microglial differentiation and maintenance 21, 22 and can induce macrophages from fibroblasts 23 . Under phase-contrast microscopy, clusters of cells were seen to delaminate toward the lumen of the cysts (Fig. 1e) , as well as directly into the outer medium or on the plastic culture surface. Figure 2a summarizes the protocol and the timeline used to generate microglia-like cells from human ES and iPS cells. When harvested and plated separately on Primaria, semi-adherent cells appear vacuolated, round and motile, and stain positive for PU.1, as well as for CD11B and allograft inflammatory factor 1 (AIF1, also known as IBA1) ( Fig. 2b,c; Supplementary Movie 1) . These markers have been used extensively to label or define microglia in various systems 24 . These cells can be further sorted by fluorescence-activated cell sorting (FACS) and are homogeneously positive for IBA1, CD45 and CD11B ( Fig. 2d,e) , with the majority of cells physically selected by the growth conditions positive for all markers. We went on to characterize these immature cells and their progeny (pMGLs). The immature pMGLs initially delaminating from YS-EBs are round, yet already highly phagocytic, as observed by the uptake of fluorescent latex beads and the appearance of filopodia and membrane ruffles, enabling the capture of nearby corpuscles such as inert plastic beads ( Fig. 2f,g and Supplementary Movies 1 and 2). The cells are highly motile and will readily migrate toward and encapsulate foreign bodies, such as fibers, that are present in the well (Fig. 2f) .
Initially, EdU incorporation was seen in 60% of nuclei from early pMGLs (2 weeks from the onset of production). After 2 months in culture, EdU incorporation showed that less than 5% of pMGLs kept in MGdM were mitotic within a 24-h period ( Fig. 2h) . Importantly, both primary fetal microglia and pMGLs could be maintained for several months in culture, despite ultimately limited renewal potential, which demonstrates their longevity.
To assess the reproducibility of the differentiation protocol, we induced microglia from 20 different ES and iPS cell lines representing a panel of healthy and disease genotypes (Supplementary Table 2 ) and successfully generated pMGLs from all lines. Supplementary  Table 2 reports quantitative output at an early cutoff of 4 weeks, which matches the cutoff for NPCs. The cumulative yields are substantially higher. For example, after 8 weeks of differentiation, hES-wibr1, iPS-wt1, iPS-wt4, iPS-ALD4 and iPS-ALD1 respectively generated 1 × 10 6 , 1 × 10 6 , 3 × 10 6 , 2 × 10 6 and 8 × 10 6 microglia-like cells from 2 × 10 6 pluripotent stem cells at the onset. We conclude that the differentiation protocol is efficient and robust, although the genetic background of the pluripotent donor affects the kinetics and yield of the microglia-like cells.
Phenotypic and functional characterization of pMGLs
In culture, monocyte-derived macrophages adopt either a "fried-egg" morphology or an axial bipolar spread, reflecting the macrophage polarization and activation status 25 . By contrast, a typical characteristic of microglia is to become highly ramified in vivo. To assess the phenotypic characteristics of the cells, we cultured pMGLs in a maintenance medium (MGM) containing high concentrations of IL-34 (100 ng/ml) and low concentrations of CSF1 (5 ng/ml) in NGD base. As shown in Figure 3a ,b and Supplementary Movies 3-5, primary mouse and human microglialike pMGLs derived from hES or hiPS cells adopted an identical morphology, characterized by multiple thin first-order branches terminated by actively motile membrane ruffles around an immobile soma.
Microglia were missing from our study of isogenic methyl-CpG binding protein 2 (MECP2) wild-type and mutant human ES-derived neural cells 26 , yet their involvement in Rett syndrome has become in recent years the focus of great interest 27 , following controversial findings that transplanted wild-type phagocytes derived from bone marrow could rescue features of Rett syndrome 28 . pMGLs have the potential to clarify some of the cell autonomous and noncell-autonomous aspects of Rett microglial biology. We derived pMGLs from isogenic male wild-type and MECP2 mutant cells and observed that mutant cells were significantly smaller than the wild-type cells (Fig. 3c) .
Mature pMGLs stained positive for markers of murine and human microglia 10, 11, 29, 30 , with both TMEM119 and P2RY12 displaying a broad membrane and punctate vesicular expression pattern, consistent with their roles as part of the microglial sensome ( Fig. 3d,e ). The majority of pMGLs at this stage were positive for TMEM119, IBA1 and CD45 (Fig. 3f) .
We assessed cytokine and chemokine profiles released in the supernatant of pMGL cultures. Unstimulated pMGLs secreted detectable levels of various cytokines and chemokines, including IL-8, C-X-C motif chemokine ligand 1 (CXCL1) or C-C motif chemokine ligand 2 (CCL2) ( Fig.  4a,b) . Furthermore, the addition of interferon (IFN-γ) and endotoxin (LPS) triggered the release of chemokine and cytokines above baseline ( Fig. 4a-d) . In particular, CXCL10, CCL3 (also known as MIP1A), IL-6 and TNF-α secretions were visibly increased within the dynamic range of this assay. We verified that this effect was detectable at the transcriptional level, with an increase in the mRNA of IL6 and TNF (Fig. 4c,d) .
These results indicate that monocultures of pMGLs can be a substrate to study the functional and morphological changes in microglia, derived from isogenic parental cells, or to screen for modulators of inflammation. pMGLs resemble primary human microglia and differ from peripheral macrophages We used the molecular signature specific to microglia, which is distinct from that of other macrophages 11, 29, 31 , to compare the transcriptome of pMGLs with that of bona fide primary human microglia. Isolated human fetal microglia and pMGLs were grown in the same maintenance medium for a week (MGM). This comparison is relevant because pMGLs are isolated directly from differentiating pluripotent stem cell cultures and grown in serum-free neuroglial-compatible conditions. We found that pMGLs display a signature that strikingly resembles that of fetal human microglia kept in the same conditions. Supplementary Table 3 shows that the top gene ontology (GO) categories coincide for both cell types. pMGLs differ in the enrichment of gene categories related to the establishment and modulation of the extracellular matrix (ECM; Supplementary Tables 4-7) . The differentially expressed genes between primary cells and in vitro-derived pMGLs did not include any of the canonical myeloid ontology terms, supporting their use as surrogates for human microglia. Several individual genes were highly expressed in primary human fetal microglia and pMGLs, consistent with their identity (Supplementary Fig. 2a ).
Among those genes were ITGAM (also known as CD11B), ITGB2, CSF1R, PTPRC (also known as CD45), IBA1, ADORA3 or LGMN. In addition, pMGLs highly expressed genes relevant to nervous system disorders, such as APOE, CD33 and TREM2 (Supplementary Fig. 2b) . Likewise, HEXB, a causal gene for lysosomal storage Sandhoff disease, was highly expressed in pMGLs, supporting the interest in microglial catabolism of GM2 ganglioside 32 . Neural progenitors derived from the same pluripotent stem cells and further differentiated into complex cultures of neurons and glia (diff. NPCs), express these genes at much lower levels ( Fig. 5; Supplementary Fig. 2) , which highlights the lack of overlap between these mesodermal and neuro-ectodermal lineages in vivo, despite their side-by-side residence in the brain.
To characterize pMGLs, we used a consensus subset of genes that is highly expressed in microglia but poorly expressed in other macrophages, combining the most relevant genes of the microglial sensome 11 , the unique TGF-β-dependent signature of microglia 29 and the microglial cassette found to be upregulated in TMEM119 + microglia during postnatal mouse development 10 (see Supplementary Table 8 for microglial genes compounded from Bennett et al. 10 ). These include genes coding for the transmembrane protein TMEM119, the proto-oncogene MERTK, the phospholipid binding protein PROS1, the putative synaptic-tagging complement factor C1QA, the inhibitory receptor LAIR1, the GPCR GPR34, the ectonucleotidase ENTPD1, the purinergic sensors P2Y12/13 and the main TGF-β signaling partners, TGF-β1 and TGF-βR1. The expression of these markers seems to be positively correlated with maturation time in vivo, increasing in adult animals, as compared to newborns 29 . Conversely, their expression seems to be negatively correlated with time in culture, being highest in freshly isolated cells and lowest in maintained primary cells and transformed lines. Most of these genes are in fact expressed at higher levels in pMGLs than in primary human fetal microglia ( Fig. 5a; Supplementary Fig. 2) , supporting their identity as in vitro-generated microglia. Notably, these genes are expressed at low levels in cultured macrophage cell lines, as well as in previously described mouse ES-derived microglia 33 . Conversely, genes such as SYTL1 (also known as SLPI), SAA1, SAA2, PRG4, CFP, CD5L and CRIP1 are expected to be highly expressed in peripheral macrophages and have low expression in microglia 11 : these genes are in the lower expression quartile of our data set. Genes such as GPR56 and BIN1 are expressed in microglia and in other CNS cell types, but have not been described in peripheral macrophages. Supplementary Figure 2c shows their expression in pMGLs, fMGs and differentiated NPCs. We performed unbiased hierarchical clustering of our data against previously published sequencing for primary and induced macrophages. As expected, all myeloid cells cluster away from parental iPS cells and NPCs. Strikingly, we find that pMGLs and primary fetal microglia cluster together, separately from other macrophages (Supplementary Fig. 3b) .
In the mouse, several microglia-specific genes seem to be upregulated in brain-resident microglia through early postnatal development 10 . For example, SELPLG, CST3, TXNIP, P2RY13, OLFML3 are upregulated (respectively 16-, 11-, 9-, 5-and five-fold) between embryonic day 17 and postnatal day 60. In our cultures, we find that SELPLG, CST3 and TXNIP are already expressed at high levels in both FMGs and pMGLs, whereas the expression levels of OLFML3 and P2RY13 are more than four-fold higher in pMGLs than in FMGs. We also note that pMGLs display high expression of both PU.1 and IRF8, but very low levels of MYB (Supplementary Fig. 3a) , an observation consistent with the emergence of microglia from PU.1 and IRF8-dependent, but MYB-independent cells [34] [35] [36] [37] .
We further performed unbiased hierarchical clustering of our data against previously published data on primary human brain cells isolated by immuno-panning, including neurons, fetal and mature astrocytes and adult microglia 31 . We find that pMGLs form a cluster with both fetal and mature primary microglia, whereas iPS-derived neural cells cluster with primary neurons and glia, close to fetal astrocytes (Fig. 5b) .
The pMGL phenotype is affected by co-cultivation with neurons
We observed that exposure to undifferentiated-neural-progenitorconditioned medium maintains the rounded phenotype of immature microglia and promotes their proliferation. We investigated whether the maturation of pMGLs in the presence of human pluripotent stem cell-derived mature neural cells would further refine their molecular signature (Fig. 6a, top) . Principal component (PC) analysis of the transcriptome revealed that primary fetal microglia and pMGLs cluster tightly together along PC1 and segregate away from differentiated neural progenitors cultured in the same conditions (Fig. 6b) . The difference between NPCs and pMGLs along PC1 might reflect the main myeloid versus neural identity, accounting for ~71% of sample variance, whereas the variation along PC2 (~14% of sample variance) might be refined by tissue residency, ECM and cell-cell interactions. To test this notion directly, we grew pMGLs in conditioned medium from differentiating neural cultures (defined before conditioning, with no other variation in recombinant growth factor concentrations). Figure 6b shows that after 2 weeks, the pMGLs partially shifted their signature toward that of primary microglia along the PC2 axis.
To test whether physical embedding and maturation of pMGLs in a 3D organotypic neuroglial environment would accentuate their branching patterns and enable us to observe their surveying behavior, we transduced immature pMGLs with a GFP lentivirus and re-aggregated the GFP-positive pMGLs with pre-differentiated neural cultures, at a stage where neurons have already become postmitotic and gliogenesis is ongoing (>4 weeks). The re-aggregates were kept either in spinning suspension cultures to maximize viability or as 200-µm-thick cultures in transwells, so as to avoid triggering pMGL activation from hypoxia of the surrounding tissue and to enable live observation. In this context, an entire spheroid or cellular stack is self-assembling, laying down its own extracellular matrix without the need for additional scaffold (Fig. 6a, bottom) . The neural progenitors progressively differentiated into neurons and macroglia (astrocytes and oligodendrocytes) and would be devoid of any microglia without the exogenous addition of pMGLs. GFP-labeled pMGLs, which had adopted rounded-to-first-order ramified morphologies when cultured on plastic, integrated into the 3D cultures, tiled the volume (Fig. 6c ) and projected highly branched ramifications (Fig. 6d) . The 3D culture matrix is a cortex-like mesh of MAP2-positive neurites and GFAPpositive astrocytic branches (Fig. 6e) . Live imaging of the GFP-positive pMGL branches in situ showed rapid extension and retraction of filopodial arbor termini (Fig. 6f,g and Supplementary Movies 6 and 7) . These results suggest that pMGLs can integrate into organotypic neural cultures and mature into what are currently defined as resting yet dynamically motile microglia. We note that this magnitude of extension and retraction is not observed in 2D cultures on Primaria or glass coverslips, on which nonamoeboid pMGLs display only terminal ruffle movement, on a much smaller scale.
Embedded pMGLs rapidly respond to cellular damage One of the characteristics of microglia in vivo is their ability to survey the parenchyma from their static tiling positions, yet revert to an amoeboid and actively migrating state in response to injury. Migration toward a site of cellular damage is driven by purinergic receptors, such as P2RY12/13, in response to ATP and ADP release from dying cells. Figure 5 pMGLs recapitulate the consensus signature distinguishing primary microglia from other macrophages. (a) Quantification of normalized expression (counts from RNA-seq data) of the indicated genes for pMGLs (black bars, n = 5), primary human fetal microglia (red bars, hFMG, n = 2) and differentiated human neural progenitors (red bars, diff. NPCs, n = 4). Data are presented as mean ± s.e.m. (b) Dendrogram depicting the results of unbiased hierarchical clustering of fMGs (n = 2), pMGLs (n = 5) and NPCs (n = 4) derived in this study, as compared to a published data set (GSE73721) 31 for adult primary microglia (n = 3), fetal astrocytes (n = 6), mature astrocytes (n = 12), neurons (n = 1) and whole cortex (n = 4), using genes in Supplementary Table 8 . We took advantage of our 3D culture system to model such localized damage and observe microglial behavior in real time. Figure 6h and Supplementary Movies 8 and 9 display the time-lapse reaction of embedded GFP + microglia to a focal laser injury (yellow arrowhead at 5′). Microglia reacted within minutes by extending a single long process toward the injury center, making contact with the damaged zone (t = 20′). They then rapidly migrated their cell bodies to surround the damaged area. By contrast, microglia away from the injury site stayed in place.
DISCUSSION
In this work, we have established a robust protocol that allows for the derivation of microglia-like cells from human pluripotent stem cells. These cells are derived in a defined medium that mimics the serumfree environment of the CNS interstitial milieu, supporting electrophysiological maturation of neurons, proliferation and maturation of astrocytes and differentiation and maintenance of oligodendrocytes.
We demonstrated that pMGLs are highly phagocytic and, on the basis of their phenotypic and gene expression profiles, resemble primary fetal and adult human microglia. In particular, they bypass a colonyforming monocytic stage and are initially amoeboid and capable of proliferation, extensive migration and phagocytosis. They eventually settle into a highly ramified morphology, enhanced by co-culture with differentiated neurons and glia. These cells express many of the markers expected to be characteristic of microglial expression phenotypes, such as P2RY12/13, HEXB, GPR34 and TMEM119. Transcriptome sequence analysis shows that they, unlike other macrophages, resemble human primary fetal and adult microglia. Primary microglia and cell lines have been maintained for short periods on canonical polymer linkers such as poly-d-lysine (PDL) plus laminin, but this is also a substrate for neural progenitors, neurons and glia. To exclude the growth of neuro-ectodermal derivatives, we used Primaria plastic to positively select pMGLs. It is notable that coatings such as PDL or matrigel can represent another layer of variability between cultures, and their exclusion contributes to the reproducibility of this protocol.
CSF1 is a primary actor of proliferation, differentiation and function of myeloid cells, but microglia develop normally in CSF1-mutant mice, although their numbers are drastically decreased in CSF1Rmutant animals 16 in comparison to wild-type mice. Therefore, it was suggested that an additional cognate ligand of CSF1R is crucial for microglia development. The addition of the recently identified alternative ligand for CSF1R, IL-34, to the base medium improved the morphological phenotype of microglia-like cells. Immature pMGLs delaminate and adopt directly a macrophage identity, with no colonyforming intermediate. This is consistent with our current understanding of microglial development, which supports the notion that microglia derive from nonmonocytic primitive myeloid cells acting as precursors, unlike adult bone marrow-derived macrophages, but similarly to some other tissue-resident macrophages 37 . As pMGLs populate the substrate, they clearly isolate from their nearest neighbors, a behavior observed in vitro that may correspond to the ability of their in vivo counterparts to tile the CNS. Unlike other tissue-resident macrophages, microglia derive from precursors dependent on the expression of PU.1 and IRF8 + and independent of MYB expression 34, 35 . In pMGLs, high expression of PU.1 and IRF8, in the absence of substantial expression of MYB, mirrors this ontogeny. When compared to fMGs, pMGLs kept in monoculture express high levels of SELPLG, TXNIP, CST3 and OLFML3, suggesting that they adopt a relatively mature profile compared to their primary counterparts.
Embryonic microglia, when first colonizing the nervous system, do not display the extensively ramified morphology observed in the adult CNS, instead adopting an amoeboid morphology as they migrate and spread through the parenchyma. Similarly, pMGLs progressively adopt a ramified morphology when cultured in isolation, as they lose their proliferation potential. In isolation, their morphology and function can be analyzed for cell-autonomous phenotypes. We showed that MECP2-mutant microglia are smaller than their isogenic counterparts: this might contribute to functional differences in Rett microglia that are worthy of further investigation.
pMGLs further adopt canonical high-order branching patterns once embedded in a differentiated neuro-glial environment. Their surveying behavior is reminiscent of that observed in vivo in the landmark two-photon imaging studies of the dynamic process motility of microglia in intact mouse brains 38 . Furthermore, they respond to localized injury by migrating and encapsulating the damaged area. pMGLs are capable of major and rapid morphological changes, as well as secretion of highly bioactive cytokines and chemokines. It will be particularly interesting to study their secretomes in the context of disease models to which we applied this paradigm.
It is well established that microglia perform key functions in the development of the brain, such as in circuit refinement, neurogenesis and neuronal growth 39 . Microglia-mediated inflammation can have deleterious consequences for the brain, and much evidence indicates that microglial activation contributes to neurodegenerative diseases such as AD, PD and ALD 40, 41 . In ALD, phagocytes derived from autologous bone marrow transplants probably elicit their beneficial effects by replacing mutant microglia, because they stall terminal neuro-inflammation and demyelination 42 . In addition, other brain dysfunctions, including depression 43 , schizophrenia and autism, have been suggested to involve microglial dysfunction. The availability of a robust protocol to generate and maintain microglia from patients with these conditions allows for study of the interaction of neurons and microglia and will facilitate the investigation of these diseases in defined culture conditions.
METHODS
Methods and any associated references are available in the online version of the paper. Accession codes. Raw data from RNA-seq analyses have been deposited in the NCBI Gene Expression Omnibus under accession number GSE85839.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METHODS

Study design.
No statistical tests were used to pre-determine sample size. Experimenters were not blinded to the genotypes or culture conditions, except for transcriptomic data in which line genotype was not explicit for analysis. Two-tailed Student's t-tests were performed where appropriate, and P < 0.05 was considered to be significant.
Statement of compliance with internal review boards (IRBs).
All experiments involving animals were performed in compliance with established animal protocol 1013-088-16 at the Whitehead Institute. All experiments involving cells from human donors were performed in compliance with MIT COHUES protocols 0612002068R009, 0809002912 and 0807002834R007.
Human ES and iPS cell cultures. Human ES cell line WIBR1/2/3 and hES-Rett were previously described 26, 44 and cultured in 5% O 2 on mitomycin C-inactivated mouse embryonic fibroblasts (MEFs) in hESC medium, containing DMEM/F12 (Thermo), 15% FBS (Hyclone), 5% knockout serum replacement (Thermo), 1% nonessential amino acids (Invitrogen), 1 mM glutamine (Thermo), 0.1 mM β-mercaptoethanol (Sigma-Aldrich) and 4 ng/ml bFGF (Thermo). Cultures were passaged manually or with 1 mg/ml collagenase type IV (Thermo) every 5-7 d. iPS-wt1/2/3, iPS-fAD2, iPS-AMN1/2/3 and iPS-ALD1/2/3/4 were reprogrammed from patient fibroblasts using the constitutive excisable STEMCCA lentivirus (OSKM) and maintained in the same conditions as WIBR1/2/3. iPS-wt4/5, iPS-fAD1/3 were reprogrammed using non-integrative Sendai virus (OSKML) and maintained on inactivated mouse embryonic fibroblasts in serum-free hES medium containing DMEM/F12 (Thermo), 20% knockout serum replacement (Thermo), 1% nonessential amino acids (Thermo), 1 mM Glutamax (Thermo), 0.1 mM β-mercaptoethanol (Sigma-Aldrich) and 12 ng/ml bFGF (Thermo). hES-WIBR3 and iPS-wt3 are female lines; all other lines are male. All parental lines were maintained for more than 50 passages, verified for stable expression of OCT3/4, Nanog and TRA1-60, and routinely tested for mycoplasma negativity.
NGD formulation justification.
We adjusted the component concentrations to match those of human cerebrospinal fluid, providing metabolic substrates necessary for individual cell types growing in the absence of others. Ionic concentrations were chosen to match human cerebrospinal fluid osmolality 45 , thus providing extracellular sodium concentrations necessary for proper electrophysiological function. We followed a rationale matched by recent efforts to improve electrophysiological activity in iPS-derived neurons 46 . Iron salts were excluded, and we instead used iron-loaded transferrin in Neurobasal to avoid dangerous redox cycling through Fenton chemistry. Glutamate was omitted to avoid the excitotoxicity of this amino acid in dissociated cultures 47 . We included additional pyruvate 48 and lactic acid 49 as energy-providing and neuroprotective substrates in addition to the more canonical oxidative substrates (glucose, galactose and glutamine (Glutamax)). Biotin and lipid-loaded albumin (Albumax) were added to support de novo synthesis lipid bilayers (for example, axons, myelin sheaths).
Differentiation to neural progenitors and maintenance. Differentiation of human ES and iPS cells into neural progenitors in 2D adherent culture was performed as follows: 2 million human ES or iPS cells were passaged onto matrigelcoated dishes using PBS without Ca 2+ /Mg 2+ , filtered through a 40-µm mesh to remove mEFS and cultured directly in NGD medium containing dorsomorphin (2.5 mM, Stemgent), bFGF (10 ng/ml, Thermo) and insulin (additional 10 ng/ml) for 3 d until they were superconfluent. bFGF and insulin were subsequently removed, and NGD + dorsomorphin was replaced every day for 10 d. Cells were subsequently passaged 1:1 with PBS −/− when rosette lawns were observed throughout the culture. Rho-associated protein kinase (ROCK) inhibitor Y27632 (10 mM, Stemgent) was added to the medium during each of the first three passages. Initial passaging at no more than 1:2 ratio, followed by 1:3 to 1:6 every 5 d. Neural progenitors were expanded and maintained in NGD medium with 10 ng/ml bFGF and an additional 10 ng/ml of insulin (NGM medium).
Differentiation toward neurons and glia. NPCs were differentiated into neurons and glia by removing FGF and culturing in NGD base levels of insulin (5 ug/ml) without retinoic acid addition (NGD contains no additional retinoid).
To initiate differentiation, NPCs were plated in a 35-mm dish on 1% matrigel at 5 × 10 5 /cm 2 and fed 5 ml of NGD every 2 or 3 d. At 4 weeks, neurons appeared in the culture, and a final dissociation was performed. The culture was dissociated in the presence of 0.05% DNase I by incubation with Accutase (Stem Cell Technologies) for 30′ at 37 °C with gentle agitation (bacterial rotator), re-suspended in chilled HBSS/0.1% BSA and filtered through a 40-µM mesh before being centrifuged through a cushion of 4% BSA to remove cellular debris. For 2D cultures and for medium conditioning, cells were re-plated at 5 × 10 5 /cm 2 on 0.1% PEI-coated plastic or glass. For re-aggregation with pMGLs, 3D cultures were initiated by plating 1.5 × 10 6 cells in a 0.3-cm 2 PET transwell with 0.4-mm pores coated with 0.1% PEI. Cells were mixed with transduced pMGLs in a 1:10 ratio. Spheroid formation was initiated by re-aggregating 3 × 10 4 NPCs per well in a 96-well ultra-low attachment plate (Corning), mixed with pMGLs at 1:10 ratio.
Differentiation toward pMGLs. Colonies were treated with collagenase IV (1.5 mg/ml) and mildly triturated to form a suspension of uniform clumps and transferred directly to 5 ml MGdM (NGD + 10 ng/ml IL-34 + 10 ng/ml CSF1) in ultra-low attachment six-well plates (Corning). Six confluent wells (~3 × 10 6 cells) were pooled into one suspension well. Embryoid bodies were monitored for the appearance of two main identifiable types. The first group was composed of compact phase-bright neuralized spheroids, and the second group was composed of large, expanding cystic bodies, YS-EBs. Every 5 d, EBs were gently triturated to shear off loose cells of interest, settled and the supernatant placed in a single well of a Primaria six-well plate. Unattached cells and small EBs were washed with fresh MGdM. Attached cells were monitored for morphological characteristics of microglial precursors (compact nucleus, vacuoles, membrane ruffles, motility), and wells from six consecutive productions (1 month) were pooled to constitute one synchronized population. Further maintenance was performed in MGM (NGD + 100 ng/ml IL-34 + 5 ng/ml CSF1). Cells are sensitive to passaging, but can be lifted with Accutase, or preferentially, with ice-cold PBS with 5 ng/ml CSF1. Assays and imaging were performed 4 or 5 d after passaging or feeding. pMGL staining displays cells derived from iPS-wt5.
Lentivirus production and transduction. FU-GFP-IRES-PURO-W lentivirus constructs were used for pMGL transduction. VSVG-coated lentiviruses were generated in HEK293 cells, as previously described 50 . Subconfluent HEK293 cells were transfected using X-tremeGENE 9 (Roche), with a mixture of lentiviral construct and second-generation packaging plasmids. Culture medium was changed 12 h after transfection and collected 96 h later. Virus-containing medium was filtered through a 0.45-µm filter and concentrated by ultracentrifugation (23 krpm, 90′, 4 °C). pMGLs cultured in MGdM were transduced at an MOI of 10 (titer assessed by p24 ELISA). Medium was replaced after 12 h, and cells were left to recover. Expression was evaluated by fluorescence microscopy without additional selection.
EdU click-it assay. EdU (10 µM, Life Technologies) was added to MGdM medium for 24 h, after which cells or tissues were fixed using ice-cold methanol. EdU click-it assay was performed on fixed cells per the manufacturer's instruction (Life Technologies), followed by fluorescent immuno-staining and imaging. Counting was performed by automated particle counting with Fiji. Data is represented as a ratio of EDU positive to DAPI positive nuclei. Six random fields were chosen at 100× magnification and averaged between two biological replicates to generate s.e.m. and t-test values.
Cell-size comparison. At least 200 cells were imaged in phase contrast in each of three replicate wells of two isogenic lines of pMGLs (Rett and control). FiJi Gaussian blur was applied to the images, followed by background subtraction and thresholding. The particle-counting function was used to measure average pixel counts (surface) of cell masks and average perimeters in each replicate. Data is given as mean ± s.e.m., with significance set as below 0.05 for the t-test.
Imaging. Cells and tissues were fixed with ice-cold methanol or 4% paraformaldehyde in PBS. After PFA fixation, permeabilization was effected with
